Price Alert

Carmell Therapeutics Corp... (CTCX)

NASDAQ: CTCX · Real-Time Price · USD

0.20

0.01 (2.77%)

At close: Mar 07, 2025, 3:55 PM

Carmell Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	1.14M	2.2M	892.16K	2.91M	7.97M	10.24K	16.13K	128.15K	376.83K	551.5K	594.73K	774.19K	849.65K	n/a	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	160.24M	158.37M	156.69M	155.36M	154.66M	154.46M	154.45M	154.44M	n/a	n/a
Other Long-Term Assets	n/a	n/a	-1	n/a	n/a	n/a	n/a	-156.69M	n/a	n/a	n/a	n/a	n/a	315.18K	82.95K
Receivables	219.64K	204.56K	204.56K	204.56K	14.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	97.89K	113.87K	n/a	n/a	9.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	1.42M	3.56M	59.02M	5.38M	n/a	n/a	422.32K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.88M	4.1M	5.19M	62.9M	38.87M	64.43K	127.21K	605.54K	529.07K	615.71K	756.08K	973.17K	1.13M	n/a	n/a
Property-Plant & Equipment	536.19K	910.93K	968.06K	1.02M	1.15M	n/a	n/a	1.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	20.78K	21.92K	23.05K	24.19K	42.2M	n/a	n/a	28.7K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	556.97K	932.85K	991.12K	1.05M	43.35M	160.24M	158.37M	1.14M	155.36M	154.66M	154.46M	154.45M	154.44M	315.18K	82.95K
Total Assets	2.44M	5.03M	6.18M	63.95M	82.22M	160.3M	158.5M	1.75M	155.89M	155.28M	155.21M	155.42M	155.58M	315.18K	82.95K
Account Payables	4.21M	4.1M	4.28M	4.42M	17.79M	2.82M	n/a	2.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	1.00	n/a	2.77M	8M	n/a	n/a	1.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	362.97K	21.29K	731.34K	1.29M	7.33M	n/a	n/a	2.78M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.51M	1.49M	1.64M	31.17M	4.77M	n/a	2.62M	1.74M	830.79K	1.06M	648.05K	330.01K	119.61K	297.75K	59.17K
Total Current Liabilities	6.17M	5.78M	6.91M	38.5M	37.71M	4.11M	2.62M	7.3M	830.79K	1.06M	648.05K	330.01K	119.61K	297.75K	59.17K
Long-Term Debt	n/a	n/a	n/a	n/a	1.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	13.52M	n/a	n/a	31.42M	5.41M	5.41M	5.41M	5.41M	5.41M	n/a	n/a
Total Long-Term Liabilities	332.57K	627.95K	666.45K	697.72K	23.6M	n/a	n/a	32.24M	5.41M	5.41M	5.41M	5.41M	5.41M	n/a	n/a
Total Liabilities	6.51M	6.41M	7.57M	39.2M	61.31M	4.11M	2.62M	39.54M	6.24M	6.47M	6.05M	5.74M	5.53M	297.75K	59.17K
Total Debt	781.7K	798.74K	1.54M	2.14M	9.71M	n/a	n/a	3.74M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	2.09K	2.09K	1.94K	2.31K	2.31K	158.59M	157.18M	14.53K	155.03M	154.46M	154.46M	154.45M	154.44M	431.00	431.00
Retained Earnings	-67.96M	-65.08M	-61.77M	-58.5M	-61.66M	-2.4M	-1.31M	-42.38M	-5.37M	-5.64M	-5.3M	-4.76M	-4.39M	-7.58K	-1.21K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-4.06M	-1.37M	-1.39M	24.75M	20.92M	156.19M	155.87M	-37.79M	149.65M	148.81M	149.16M	149.69M	150.05M	17.42K	23.79K
Total Investments	n/a	n/a	n/a	n/a	n/a	160.24M	158.37M	156.69M	155.36M	154.66M	154.46M	154.45M	154.44M	n/a	n/a